• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • RVU Search
    • NPI Registry Lookup
  • Pharma
  • AI News
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • RVU Search
    • NPI Registry Lookup
  • Pharma
  • AI News
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home The Classics General Medicine Classics

Intravenous omeprazole after endoscopy reduces rebleeding in patients with peptic ulcers [Classics Series]

bys25qthea
December 6, 2013
in General Medicine Classics, Surgery Classics, The Classics
Reading Time: 2 mins read
0
Share on FacebookShare on Twitter

Image: CC/L. academia

1. After endoscopic treatment, intravenous omeprazole significantly reduces the risk of rebleeding in patients with peptic ulcers at 3, 7, and 30 days

Original Date of Publication: August 3, 2000

Study Rundown: The findings of this trial demonstrate the value of a proton pump inhibitor in reducing the risk of rebleeding in patients with peptic ulcers. The fact that this study was carried out at a single centre in a predominantly Chinese population may limit the generalizability of the study. Moreover, the use of intravenous omeprazole is another concern, as it may not be available in certain other practice settings. Other studies, however, have demonstrated similar benefits with using orally administered proton pump inhibitors.

In sum, intravenous omeprazole reduces the risk of rebleeding in patients with bleeding peptic ulcers after endoscopic treatment.

Click to read study in NEJM

RELATED REPORTS

Wide-awake local anesthesia without a tourniquet may achieve similar anesthetic success to ultrasound-guided axillary brachial plexus block

Fecal calprotectin is a useful marker for defining small bowel endoscopic remission in Crohn’s disease

High flow nasal cannula reduces hypoxia for obese patients undergoing endoscopy

In-Depth [randomized controlled study]: This trial, published in 2000 in NEJM, sought to explore the value of intravenous omeprazole after endoscopy to reduce the risk of rebleeding in patients with peptic ulcers. After endoscopic treatment, bleeding peptic ulcers have been shown to rebleed in 15-20 percent of patients, though acid suppression may help stabilize clots and reduce the bleeding risk.

The trial was conducted at the Chinese University of Hong Kong. A total of 240 patients were randomized to receive either intravenous omeprazole (i.e., 80 mg bolus, then 8 mg/hour for 72 hours) or placebo after endoscopic treatment for bleeding peptic ulcers. Treatment with omeprazole significantly reduced the risk of recurrent bleeding at days 3, 7, and 30 compared to placebo. Moreover, omeprazole significantly reduced the length of hospitalization and blood transfusion requirements, though there were no significant differences in mortality between the two groups.

By Adrienne Cheung, Andrew Cheung, M.D.

© 2013 2minutemedicine.com. All rights reserved. No works may be reproduced without written consent from 2minutemedicine.com. Disclaimer: We present factual information directly from peer reviewed medical journals. No post should be construed as medical advice and is not intended as such by the authors or by 2minutemedicine.com. PLEASE SEE A HEALTHCARE PROVIDER IN YOUR AREA IF YOU SEEK MEDICAL ADVICE OF ANY SORT. Content is produced in accordance with fair use copyrights solely and strictly for the purpose of teaching, news and criticism. No benefit, monetary or otherwise, is realized by any participants or the owner of this domain.

Tags: endoscopyomeprazolepeptic ulcers
Previous Post

Chlorhexidine bathing significantly reduces the development of hospital-acquired blood-stream infections

Next Post

Study hints at causal link between lipoprotein(a) and calcific aortic stenosis

RelatedReports

Social networks play key roles in parental vaccination decisions
Imaging and Intervention

Wide-awake local anesthesia without a tourniquet may achieve similar anesthetic success to ultrasound-guided axillary brachial plexus block

January 13, 2026
Biosimilar to infliximab shows equivalent safety and efficacy for treating Crohn’s disease
Chronic Disease

Fecal calprotectin is a useful marker for defining small bowel endoscopic remission in Crohn’s disease

July 7, 2025
Covered self-expanding metallic stents noninferior to plastic stents in benign biliary strictures
Gastroenterology

High flow nasal cannula reduces hypoxia for obese patients undergoing endoscopy

February 19, 2025
Quick Take: Combined Surgery and Extensive Intraoperative Peritoneal Lavage vs Surgery Alone for Treatment of Locally Advanced Gastric Cancer: The SEIPLUS Randomized Clinical Tria
Gastroenterology

Endoscopic semi-blunt dissection technique safe and effective for gastric submucosal tumors

February 17, 2025
Next Post

Study hints at causal link between lipoprotein(a) and calcific aortic stenosis

Surgical crisis checklists improve performance during operating-room crisis simulations

Ethical argument for opt-out approach to DNR status in terminally ill children

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Adults with attention-deficit/hyperactivity disorder are at higher risk of poor long-term adherence to antihypertensive therapy
  • 150 minutes of moderate-to-vigorous physical activity per week may reduce cardiovascular risk in overweight or obese adults
  • 2 Minute Medicine: Pharma Roundup – Merck and Mayo Clinic’s AI precision medicine lab, Novartis’ remibrutinib hits Phase III hive endpoint, FDA grants priority review for iberdomide in myeloma, oral infigratinib boosts growth velocity in achondroplasia, and shingles vaccine/sildenafil linked to lower Alzheimer’s risk [February 2026]
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2025 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • RVU Search
    • NPI Registry Lookup
  • Pharma
  • AI News
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
No Result
View All Result

© 2025 2 Minute Medicine, Inc. - Physician-written medical news.